Low utilization of obesity medications: What are the implications for clinical care?
Obesity (Silver Spring)
.
2016 Sep;24(9):1832.
doi: 10.1002/oby.21566.
Authors
Theodore K Kyle
1
,
Fatima Cody Stanford
2
3
4
Affiliations
1
ConscienHealth, Pittsburgh, Pennsylvania, USA.
2
Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
3
Division of Endocrinology, Department of Pediatrics, Massachusetts General Hospital, Massachusetts, USA.
4
Harvard Medical School, Boston, Massachusetts, USA.
PMID:
27569116
PMCID:
PMC6100736
DOI:
10.1002/oby.21566
No abstract available
Publication types
Comment
MeSH terms
Drug Utilization*
Humans
Obesity*
Grants and funding
L60 MD008320/MD/NIMHD NIH HHS/United States